Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures
Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis, the most recognized type of autoimmune encephalitis, manifests with rapid cognitive decline, psychosis, and seizures that develop in 78–86% of patients. Recently, anti-NMDAR encephalitis was reported in association with demyelinating dise...
Main Authors: | Olga Taraschenko, Rana Zabad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Epilepsy & Behavior Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986419301145 |
Similar Items
-
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
by: Te-Yu Hung, et al.
Published: (2011-12-01) -
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
by: J Gordon Millichap
Published: (2013-05-01) -
Anti-N-methyl-D-aspartate receptor encephalitis: a new autoimmune encephalitis
by: Xiang-jun Chen, et al.
Published: (2013-01-01) -
ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS (CASE REPORTS)
by: E. A. Kondratyeva, et al.
Published: (2018-04-01) -
Psychosis associated with anti-N-methyl-d-aspartate receptor encephalitis
by: Udayan Bhaumik, et al.
Published: (2020-04-01)